First Trust Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-6,703
| Closed | -$307K | – | 2351 |
|
|
2020
Q3 | $307K | Buy |
6,703
+1,812
| +37% | +$83K | ﹤0.01% | 2156 |
|
|
2020
Q2 | $246K | Buy |
+4,891
| New | +$246K | ﹤0.01% | 2190 |
|
|
2019
Q4 | – | Sell |
-8,797
| Closed | -$529K | – | 2403 |
|
|
2019
Q3 | $529K | Sell |
8,797
-32,838
| -79% | -$1.97M | ﹤0.01% | 2098 |
|
|
2019
Q2 | $3.51M | Buy |
41,635
+16,401
| +65% | +$1.38M | 0.01% | 1257 |
|
|
2019
Q1 | $2.41M | Buy |
25,234
+2,681
| +12% | +$256K | ﹤0.01% | 1441 |
|
|
2018
Q4 | $1.6M | Sell |
22,553
-24,766
| -52% | -$1.75M | ﹤0.01% | 1601 |
|
|
2018
Q3 | $4.04M | Sell |
47,319
-21,957
| -32% | -$1.88M | 0.01% | 1261 |
|
|
2018
Q2 | $8.03M | Buy |
+69,276
| New | +$8.03M | 0.02% | 873 |
|
|
2016
Q2 | – | Sell |
-49,119
| Closed | -$1.44M | – | 2303 |
|
|
2016
Q1 | $1.44M | Buy |
49,119
+7,496
| +18% | +$220K | ﹤0.01% | 1474 |
|
|
2015
Q4 | $1.37M | Buy |
+41,623
| New | +$1.37M | ﹤0.01% | 1613 |
|